ST
Silvan Tuerkcan Citizens Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
26%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
95.7%
Neutral
4.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Real Estate
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Real Estate
Mortgage REIT
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Market Outperform
Reiterated
| $86 |
63%
upside
| 3 | +8.7% |
0
%
| 23 Dec ‘25 5 months ago |
|
|
|
Market Outperform
Maintained
| $57 |
8%
upside
| 4 | +139% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Market Outperform
Maintained
| $10 |
95%
upside
| 5 | +31% |
0
%
| 20 Nov ‘25 6 months ago |
|
|
|
Market Outperform
Maintained
| $21 |
1,086%
upside
| 2 | +51% |
0
%
| 12 Nov ‘25 7 months ago |
|
|
|
Market Outperform
Maintained
| $21 |
41%
upside
| 4 | -11% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Market Outperform
Maintained
| $8 |
34%
upside
| 3 | +40% |
0
%
| 5 Nov ‘25 7 months ago |
|
|
|
Market Outperform
Maintained
| $22 |
94%
upside
| 5 | -3.2% |
0
%
| 4 Nov ‘25 7 months ago |
|
|
|
Market Outperform
Maintained
| $6 |
1,149%
upside
| 2 | -35% |
0
%
| 22 Sep ‘25 8 months ago |
|
|
|
Market Outperform
Maintained
| $34 |
272%
upside
| 1 | -61% |
0
%
| 8 Sep ‘25 9 months ago |
|
|
|
Market Outperform
Maintained
| $45 |
49%
upside
| 2 | +16% |
0
%
| 8 Sep ‘25 9 months ago |
|
|
|
Market Outperform
Reiterated
| $50 |
6%
downside
| 3 | +4.7% |
0
%
| 29 Jul ‘25 10 months ago |
|